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T h e  role of adrenocortical steroids 
in reversing established 
T. L. MARCHIORO. M.D.* 
homograft rejection 
A lthough adrenocortical steroids have 
- 
often been used clinically in an attempt to 
prevent the rejection of renal homografts: 
the sphere of usefulness of these drugs has 
not been clearly defined. The potentiation of 
graft survival with steroids alone is a feeble 
effect, as is demonstrated clearly only under 
special experimental circumstances. 
The present study is concerned with the 
evaluation of a different use of steroid 
therapy. Renal homografts were performed 
in dogs and antirejection therapy provided 
with a cytotoxic drug. When evidence of 
rejection developed, prednisolone was added 
to the pre-existing treatment. Evidence has 
been obtained which demonstrates that pred- 
nisolone can halt and reverse a rejection 
process under these circumstances. The data 
suggest that a rational and consistently suc- 
cessful program for clinical use can be 
evolved, with the use of steroids as an emer- 
gency measure at the time of rejection. 
METHODS 
Eight mongrel dogs were used, weighing 
10 to 20 kilograms. In a one-stage operation, 
bilateral nephrectomy was performed, and 
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in each case a renal homograft obtained from 
an unrelated dog was transplanted to the 
pelvis. Donor left kidney was placed into the 
right pelvis and donor right kidney into the 
left pelvis. The donor animals were cooled 
to 30' C. before operation and given heparin 
intravenously, 3 mg. per kilogram, before 
removal of the homograft. The periods of 
renal ischemia lasted 17 to 30 minutes. 
All 8 animals were treated with azathio- 
prine (BW 57-322, Imuran) for the entire 
period of survival, in a dose of 2 to 7.5 mg. 
per kilogram per day. I n  addition, 5 of the 8 
animals received preliminary thymectomy 5 
to 10 days before transplantation. All but 1 
of the dogs had splenectomy performed at 
the time of homografting and bilateral 
nephrectomy (Table I ) .  
Prednisolone was started after it became 
certain that the process of rejection had be- 
gun. The chief criteria used to determine 
this were rising blood urea nitrogen (BUN) 
levels, reduction of urine volume, and the 
development of proteinuria. After biochemi- 
cal evidence of rejection had become clear, 
prednisolone therapy was started with a dose 
of 50 to 200 mg. per day given intramuscu- 
larly. In  2 of the animals, prednisolone was 
withdrawn after the BUN level had returned 
to normal. Complete autopsies were per- 
formed on all dogs, including histologic stud- 
ies, in order to rule out factors other than re- 
jection which might have accounted for 
death. 
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Table I 
RESULTS 
Onset of uremia. Despite the antirejection 
Sur-  
D o ;  Adjuvan t  Drug uiual 
no. surgery therapy (days )  
therapy, uremia developed from 4 to 32 days 
after renal homotransplantation (Table I ) .  
Before therapy with prednisolone was begun, 
the rising trend of the BUN level was con- 
firmed on at least 2 occasions. 
Influence of steroids on uremia. In 7 of the 
8 animals, the BUN level stopped rising after 
prednisolone treatment was begun and 
within 2 to 7 days began to fall. In  2 animals, 
the fall was temporary, and after several 
days, a secondary rise occurred despite con- 
tinuation of prednisolone (Fig. 1 ) .  Death 
under these circumstances followed rapidly. 
In  2 other cases, steroids were slowly with- 
drawn after the rejection crisis had ap- 
parently passed, and the BUN level, which 
had dropped toward normal, did not mani- 
fest a secondary elevation (Fig. 2 ) .  In  4 ani- 
mals, the uremia waxed or waned with the 
withdrawal or administration of prednisolone 
therapy. 
Survival. The animals lived from 7 to 28 
days after uremia had become well estab- 
lished, and after the beginning of steroid 
KP5 Splenectomy Imuran 36 1 + 11 Yes No Undetermined 
KH6 Splenectomy Imuran 14 2 + 7 No Yes Gastrointestinal 
hemorrhage 
TK22 Splenectomy Imuran 54 2 + 26 Yes Yes Gastrointestinal 
and thymec- hemorrhage 
tomy 
TK23 Splenectomy Imuran 53  0 3 2 Yes Yes Gastrointestinal 
and thymec- hemorrhage 
tomy 
TK26 Splenectomy Imuran 11 2 + 4 Yes No Lobar pneumonia 
and thymec- 
tomy 
TK27 Splenectomy Imuran 27 2 + 13 Yes Yes Gastrointestinal 
and thymec- hemorrhage 
tomy 
TK36 Splenectomy Imuran 32 2 + 19 Yes Yes Rejection, gastro- 
and thymec- intestinal hemor- 
tomy rhage 
K I  1 None Imuran 43 1+ 19 Yes Yes Gastrointestinal 
hemorrhage, 
Pulmonary em- 
embolus 
Histologic 
rejection 
(0 to  4+) 
therapy. The longest survival in this series 
of animals was 54 days. 
Although the steroids apparently resulted 
in alleviation of the uremic state in 7 of the 
8 animals, it appeared to impose limitations 
on the total survival time, inasmuch as 6 of 
the 8 animals eventually developed serious 
Cause of death 
Onset  of 
uremia after 
transplant 
(days )  
PREDNISOLONE _ , __ 
5 1 m g m / d o ~  I 
lo' ' ' b 2 4 ' 6 6 ' io' 12  14 16 i8'20'i2'i426' 
-TIME IN DAYS- 
Responre 
to  
steroids 
Fig. 1. Reduction in BUN in animal under con- 
comitant azathioprine therapy. Note secondary rise 
of BUN when azathioprine was reduced, despite 
continuation of prednisolone. Dog died of gastric 
Gastro- 
intestinal 
hemorrhage 
hemorrhage. 
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Fig. 2. KP5. Effect of prednisolone on BUN in 
dog undrrgoing rejection despite therapy with 
azathioprine. Note reversal of azotemia. BUN levcl 
did not rise again when prednisolone was discon- 
tinued. 
ga\trointestinal hemorrhage, which was 
either the direct or contributing cause of 
death in each case. 
Autopsy findings. All but one of the dogs 
showed some evidence of rejection of the 
renal homograft at the time of death. This 
was generally rather mild in nature, consist- 
ing chiefly of a scattered mononuclear in- 
filtrate (Fig. 3 ) .  Ulceration and hemorrhage 
of the ga~trointestinal tract was found in all 
but 2 of the animals, usually involving the 
gastric antrum (Fig. 4) ,  the duodenum, and 
thc upper jejunum, but involving the entire 
ali~rlentary tract in 2 of the dogs. The ulcers 
were penetrating, with minimal histologic 
evidence of healing. The lymph nodes in all 
animals had depleted germinal centers (Fig. 
5) ,  a finding commonly observed by others 
after treatment with high doses of adreno- 
cortical steroids. 
DISCUSSION 
The effect of adrenal cortical extracts on 
mitigation of the homograft rejection pro- 
cess has been extensively studied. I t  would 
seem reasonable to expect a modification of 
the rejection reaction, inasmuch as some of 
the steroids decimate the lymphocyte popu- 
l a t i o n , b n d  because steroids inhibit the 
synthesis of various antibodies.', l6 Early in- 
vestigators showed a definite prolongation of 
skin graft survival in animals treated with 
cortisone a ~ e t a t e . ~ ?  13, l4 The experiments 
were conducted under highly controlled con- 
ditions, employing inbred test animals. In 
general, cortisone and cortisol had the great- 
est efficacy, ACTH had a feeble effect, and 
corticosterone was without value. 
Under less rigidly controlled conditions, 
the effect of steroid therapy on homograft 
survival has been difficult to demonstrate. 
Ellison and associates6 were unable to find 
prolongation of skin graft survival in hu- 
mans under therapy with cortisone. Demp- 
ster,%orking with greyhound dogs, was un- 
able to prolong the survival of renal homo- 
Fig. 3. KP5. Microscopic section of 
kidney in same animal as Fig. 2. Ani- 
mal lived 25 days after onset of ure- 
mia. Rejection is minimal. (Originai 
magnification ~ 1 6 0 . )  
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Fig. 4. TK27. Death resulted from gastrointestinal hemorhage while on steroid therapy. A, 
gross view of antral ulcer. B, microscopic view. Not minimal healing. (Original magnification 
x250.) 
grafts despite the administration of 150 to undergoing rejection. He showed that the 
200 mg. of cortisone acetate per day. His vascular endothelial reaction in the rejection 
~neticulous histologic and physiologic studies, of renal homografts was materially reduced, 
however, provided a rationale for the use of that the plasma cell and lymphocyte infiltra- 
steroid therapy for renal homotransplants tion was moderated, and that the arteriolar 
Fig. 5.  Lymph node from TK27. Note depletion of follicles. (Original mag- 
nification X I  60.) 
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constriction characterizing the active rejec- 
tion process was reduced, which thereby 
provided a better peripheral blood supply to 
the kidney while it was under immunologic 
attack. 
Most of the foregoing studies have sug- 
gested that steroid therapy in large doses 
modified homograft rejection slightly, but 
that this effect was so feeble as to be of little 
clinical value. A few isolated observations 
have suggested that steroids might be of 
more substantial value when used in com- 
bination with other agents. Baker and as- 
sociate~,~ on the basis of limited data, con- 
cluded that the combination of nitrogen 
mustard and cortisone had a greater poten- 
tiating effect on graft survival than either 
agent alone. Goodwin and co-workers7 re- 
cently reported a clinical case in which a 
vigorous rejection occurred 35 days after the 
transplantation of a kidney from a mother 
to her daughter. Forty days after operation, 
200 mg. per day of prednisone was added to 
the pre-existing therapy of nitrogen mustard 
and cytoxan. There was gradual clearing of 
the azotemia. Although the child died 4 
months later, the state of histologic preserva- 
tion of the homograft was surprisingly nor- 
mal. Merrill and associates,12 in treating late 
rejection in a kidney donated by one fraternal 
twin to another, employed supplementary 
irradiation plus intermittent steroid therapy. 
Attacks of rejection were aborted but the 
roles of the irradiation and steroid therapy 
are difficult to separate. 
The present study serves to focus atten- 
tion on the value of steroids as supplemen- 
tary therapy in patients receiving continuous 
treatment with more powerful agents. If, as 
in the present experimental series, day-to-day 
therapy is provided with azathioprine, the 
steroids can be withheld until the onset of 
rejection. With the advent of azotemia or 
proteinuria, the use of steroids in large doses 
has led to the consistent regression of uremia. 
I? some of the animals, furthermore, this 
restoration of the BUN level to or toward 
normal persisted, even after a total with- 
drawal of the prednisolone. 
The matter of timing of institution of 
steroid therapy has also been clarified to 
some extent by the present experiments. I t  
is clear that withholding this adjuvant 
therapy until the onset of rejection does not 
diminish its therapeutic efficacy. This would 
appear to be an important feature in view 
of the high incidence of gastrointestinal ul- 
cerations in the present series of animals. 
These observations have strongly influenced 
our policy in clinical cases. Large doses of 
steroids (200 to 300 mg. per day of predni- 
sone) have been used only with the specific 
indication of rejection, and they have then 
been withdrawn as rapidly as possible after 
the threat of rejection has passed. In 9 clini- 
cal cases1' in which steroids have been used, 
there has been only 1 instance of acute gas- 
trointestinal hemorrhage, probably because 
all the patients have been on vigorous con- 
comitant antacid therapy. Nevertheless, the 
hazards involved in the clinical use of ste- 
roids are undoubtedly real. 
SUMMARY 
Renal homotransplantation was performed 
in 8 dogs. Antirejection therapy with aza- 
thioprine (BW 57-322, Imuran) was given in 
doses of 2 to 7.5 mg. per kilogram per day. 
Evidence of rejection developed in all animals 
from 4 to 32 days following transplantation. 
When rejection had been established by at 
least 2 successive elevations of the BUN level, 
intramuscular injections of prednisolone (50 
to 200 mg. per day) were added to the pre- 
existing azathioprine therapy. Seven of the 
8 animals had a favorable response evidenced 
by a falling BUN level, increased urine vol- 
umes, and decreasing proteinuria. 
Gastrointestinal bleeding was a serious 
complication in 6 of the 8 dogs. I t  was a 
direct or contributing cause of death in all 6. 
The rationale for the use of prednisolone 
in homotransplantation is discussed. From 
these experiments it would appear to be a 
valuable adjunct in reversing established re- 
jection when added in large doses to pre- 
existing antirejection therapy with azathio- 
prine. Vigorous antacid therapy is indicated 
to prevent gastrointestinal ulceration and 
bleeding. 
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